Natures Sunshine Products price to free cash flow NATR

Market value divided by free cash flow over the last twelve months, since 2012.

Today, Oct 23, 2026: 11.8×
9-year median: 14.9×
Against its 9-year history: 17th; percentile: 0 is its lowest day, 100 its highest
9-year range: 7.4× to 49.9×
Peer median: 11.0×

Natures Sunshine Products' price to free cash flow is 11.8× as of Oct 23, 2026.

That is below its 9-year median of 14.9×, lower than on 83% of days in the last 9 years.

Over that time it ranged from 7.4× in Jun 2020 to 49.9× in May 2020.

The median for 10 large drugmakers of a similar size is 11.0×.

Price to free cash flow over time

median 14.9×

The dashed line is the 9-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	11.8×	11.7×	18.5×
2025	12.1×	10.0×	21.3×
2024	21.9×	11.6×	23.6×
2023	14.3×	13.6×	44.6×
2022	34.0×	11.5×	36.8×
2021	14.6×	10.2×	18.6×
2020	11.4×	7.4×	49.9×
2019	22.0×	10.2×	30.6×
2018	13.4×	9.8×	41.6×
2017	n/m a value too high to mean anything
2016	n/m a value too high to mean anything
2015	n/m a value too high to mean anything
2014	54.6×	9.5×	60.2×
2013	11.0×	9.0×	13.2×
2012	12.0×	12.0×	13.1×

Against its peers

Companies in Drug Manufacturers - General nearest Natures Sunshine Products' size, closest first, today.

Company	Price to free cash flow
NATRNatures Sunshine Products	11.8×
ARVNArvinas	n/m
PBYIPuma Biotechnology	13.8×
IRWDIronwood Pharmaceuticals	n/m
ZVRAZevra Therapeutics	17.9×
CRMDCorMedix	2.4×
LFVNLifevantage	11.0×
SPROSpero Therapeutics	n/m
COLLCollegium Pharmaceutical	2.3×
ABUSArbutus Biopharma	n/m
ATNMActinium Pharmaceuticals	n/m
Peer median	11.0×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Natures Sunshine Products

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.